Adcetris is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
The “Adcetris Industry Forecast” looks at past sales and reviews total world Adcetris sales in 2022, providing a comprehensive analysis by region and market sector of projected Adcetris sales for 2023 through 2029. With Adcetris sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adcetris industry.
This Insight Report provides a comprehensive analysis of the global Adcetris landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adcetris portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Adcetris market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adcetris and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adcetris.
The global Adcetris market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Adcetris is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adcetris is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adcetris is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adcetris players cover Seattle Genetics and Takada etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Adcetris market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Podwer
Liquid
Segmentation by application
Hospital
Drugs Store
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Seattle Genetics
Takada
Key Questions Addressed in this Report
What is the 10-year outlook for the global Adcetris market?
What factors are driving Adcetris market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adcetris market opportunities vary by end market size?
How does Adcetris break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adcetris Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Adcetris by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Adcetris by Country/Region, 2018, 2022 & 2029
2.2 Adcetris Segment by Type
2.2.1 Podwer
2.2.2 Liquid
2.3 Adcetris Sales by Type
2.3.1 Global Adcetris Sales Market Share by Type (2018-2023)
2.3.2 Global Adcetris Revenue and Market Share by Type (2018-2023)
2.3.3 Global Adcetris Sale Price by Type (2018-2023)
2.4 Adcetris Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Adcetris Sales by Application
2.5.1 Global Adcetris Sale Market Share by Application (2018-2023)
2.5.2 Global Adcetris Revenue and Market Share by Application (2018-2023)
2.5.3 Global Adcetris Sale Price by Application (2018-2023)
3 Global Adcetris by Company
3.1 Global Adcetris Breakdown Data by Company
3.1.1 Global Adcetris Annual Sales by Company (2018-2023)
3.1.2 Global Adcetris Sales Market Share by Company (2018-2023)
3.2 Global Adcetris Annual Revenue by Company (2018-2023)
3.2.1 Global Adcetris Revenue by Company (2018-2023)
3.2.2 Global Adcetris Revenue Market Share by Company (2018-2023)
3.3 Global Adcetris Sale Price by Company
3.4 Key Manufacturers Adcetris Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adcetris Product Location Distribution
3.4.2 Players Adcetris Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Adcetris by Geographic Region
4.1 World Historic Adcetris Market Size by Geographic Region (2018-2023)
4.1.1 Global Adcetris Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Adcetris Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Adcetris Market Size by Country/Region (2018-2023)
4.2.1 Global Adcetris Annual Sales by Country/Region (2018-2023)
4.2.2 Global Adcetris Annual Revenue by Country/Region (2018-2023)
4.3 Americas Adcetris Sales Growth
4.4 APAC Adcetris Sales Growth
4.5 Europe Adcetris Sales Growth
4.6 Middle East & Africa Adcetris Sales Growth
5 Americas
5.1 Americas Adcetris Sales by Country
5.1.1 Americas Adcetris Sales by Country (2018-2023)
5.1.2 Americas Adcetris Revenue by Country (2018-2023)
5.2 Americas Adcetris Sales by Type
5.3 Americas Adcetris Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adcetris Sales by Region
6.1.1 APAC Adcetris Sales by Region (2018-2023)
6.1.2 APAC Adcetris Revenue by Region (2018-2023)
6.2 APAC Adcetris Sales by Type
6.3 APAC Adcetris Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Adcetris by Country
7.1.1 Europe Adcetris Sales by Country (2018-2023)
7.1.2 Europe Adcetris Revenue by Country (2018-2023)
7.2 Europe Adcetris Sales by Type
7.3 Europe Adcetris Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adcetris by Country
8.1.1 Middle East & Africa Adcetris Sales by Country (2018-2023)
8.1.2 Middle East & Africa Adcetris Revenue by Country (2018-2023)
8.2 Middle East & Africa Adcetris Sales by Type
8.3 Middle East & Africa Adcetris Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adcetris
10.3 Manufacturing Process Analysis of Adcetris
10.4 Industry Chain Structure of Adcetris
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adcetris Distributors
11.3 Adcetris Customer
12 World Forecast Review for Adcetris by Geographic Region
12.1 Global Adcetris Market Size Forecast by Region
12.1.1 Global Adcetris Forecast by Region (2024-2029)
12.1.2 Global Adcetris Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Adcetris Forecast by Type
12.7 Global Adcetris Forecast by Application
13 Key Players Analysis
13.1 Seattle Genetics
13.1.1 Seattle Genetics Company Information
13.1.2 Seattle Genetics Adcetris Product Portfolios and Specifications
13.1.3 Seattle Genetics Adcetris Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Seattle Genetics Main Business Overview
13.1.5 Seattle Genetics Latest Developments
14 Research Findings and Conclusion
*If Applicable.